Halozyme Therapeutics Statistics

Total Valuation

LON:0J2O has a market cap or net worth of GBP 4.83 billion. The enterprise value is 5.42 billion.

Market Cap	4.83B
Enterprise Value	5.42B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	123.22M
Shares Outstanding	n/a
Shares Change (YoY)	-2.34%
Shares Change (QoQ)	-1.81%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	121.83M

Valuation Ratios

The trailing PE ratio is 12.86 and the forward PE ratio is 8.79.

PE Ratio	12.86
Forward PE	8.79
PS Ratio	5.76
PB Ratio	12.94
P/TBV Ratio	n/a
P/FCF Ratio	12.59
P/OCF Ratio	12.39
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.70, with an EV/FCF ratio of 14.12.

EV / Earnings	14.42
EV / Sales	6.73
EV / EBITDA	10.70
EV / EBIT	12.21
EV / FCF	14.12

Financial Position

The company has a current ratio of 8.39, with a Debt / Equity ratio of 3.19.

Current Ratio	8.39
Quick Ratio	7.00
Debt / Equity	3.19
Debt / EBITDA	2.25
Debt / FCF	3.10
Interest Coverage	32.99

Financial Efficiency

Return on equity (ROE) is 147.06% and return on invested capital (ROIC) is 20.02%.

Return on Equity (ROE)	147.06%
Return on Assets (ROA)	18.49%
Return on Invested Capital (ROIC)	20.02%
Return on Capital Employed (ROCE)	29.20%
Revenue Per Employee	2.40M
Profits Per Employee	1.07M
Employee Count	350
Asset Turnover	0.54
Inventory Turnover	1.55

Taxes

In the past 12 months, LON:0J2O has paid 92.55 million in taxes.

Income Tax	92.55M
Effective Tax Rate	19.77%

Stock Price Statistics

The stock price has increased by +5.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.16%
50-Day Moving Average	56.91
200-Day Moving Average	55.90
Relative Strength Index (RSI)	40.21
Average Volume (20 Days)	1,313

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.76

Income Statement

In the last 12 months, LON:0J2O had revenue of GBP 839.24 million and earned 375.67 million in profits. Earnings per share was 2.91.

Revenue	839.24M
Gross Profit	639.23M
Operating Income	462.43M
Pretax Income	468.21M
Net Income	375.67M
EBITDA	521.07M
EBIT	462.43M
Earnings Per Share (EPS)	2.91

Full Income Statement

Balance Sheet

The company has 578.88 million in cash and 1.19 billion in debt, giving a net cash position of -610.61 million.

Cash & Cash Equivalents	578.88M
Total Debt	1.19B
Net Cash	-610.61M
Net Cash Per Share	n/a
Equity (Book Value)	373.27M
Book Value Per Share	3.03
Working Capital	860.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 389.98 million and capital expenditures -6.27 million, giving a free cash flow of 383.71 million.

Operating Cash Flow	389.98M
Capital Expenditures	-6.27M
Free Cash Flow	383.71M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.17%, with operating and profit margins of 55.10% and 44.76%.

Gross Margin	76.17%
Operating Margin	55.10%
Pretax Margin	55.79%
Profit Margin	44.76%
EBITDA Margin	62.09%
EBIT Margin	55.10%
FCF Margin	45.72%

Dividends & Yields

LON:0J2O does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.34%
Shareholder Yield	n/a
Earnings Yield	7.78%
FCF Yield	7.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0J2O has an Altman Z-Score of 4.63 and a Piotroski F-Score of 7.

Altman Z-Score	4.63
Piotroski F-Score	7